BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 8:24:11 AM | Browse: 374 | Download: 1121
 |
Received |
|
2021-03-29 02:49 |
|
Peer-Review Started |
|
2021-03-29 02:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-28 22:47 |
|
Revised |
|
2021-05-07 09:14 |
|
Second Decision |
|
2021-05-24 09:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-24 10:29 |
|
Articles in Press |
|
2021-05-24 10:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-31 02:26 |
|
Typeset the Manuscript |
|
2021-07-13 05:08 |
|
Publish the Manuscript Online |
|
2021-07-21 08:24 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying Zhang, Jia-Yun Zou, Yan-Yan Xu and Jing-Ni He |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jing-Ni He, MD, PhD, Associate Professor, Attending Doctor, Surgeon, Department of General Surgery, Shengjing Hospital of China Medical University, No. 39 Huaxiang Street, Shenyang 110022, Liaoning Province, China. hejn@sj-hospital.org |
| Key Words |
Neoplastic pericardial effusion; Rectal cancer; Fruquintinib; Anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor; Case report |
| Core Tip |
Neoplastic pericardial effusion (NPE) is a rare consequence of rectal cancer and carries a poor prognosis. We report an elderly patient with NPE from rectal cancer who responded to the use of fruquintinib. In March 2015, a 65-year-old Chinese woman diagnosed with adenocarcinoma of the rectum. By October 2018, FOLFIRI and FOLFOX chemotherapeutic regimens were administered as first- and second-line treatments. After two cycles of second-line agents, she was diagnosed with NPE. Single-agent fruquintinib was initiated as a third-line therapeutic. The recurrence-free interval for NPE was 9.2 mo, attesting to the efficacy of fruquintinib. |
| Publish Date |
2021-07-21 08:24 |
| Citation |
Zhang Y, Zou JY, Xu YY, He JN. Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report. World J Clin Cases 2021; 9(21): 6170-6177 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i21/6170.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i21.6170 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
